ivabradine

The drug is intended for the symptomatic treatment of chronic stable angina in adults, as well as for the treatment of chronic heart failure (NYHA class II–IV) under certain conditions.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: KRKA, d.d., Novo mesto (manufacturing 'in bulk', primary and secondary packaging, quality control and batch release) / KRKA, d.d., Novo mesto (batch control)

The drug is indicated for the symptomatic treatment of chronic stable angina in adults, as well as for the treatment of chronic heart failure (NYHA class II–IV) under certain conditions.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: KRKA, d.d., Novo mesto (manufacturing 'in bulk', primary and secondary packaging, quality control and batch release) / KRKA, d.d., Novo mesto (batch control)

The drug is intended for the symptomatic treatment of chronic stable angina pectoris in adults, as well as for reducing the risk of cardiovascular events in patients with chronic heart failure (provided there is a normal sinus rhythm and a heart rate of no less than 70 bpm).

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Laboratoires Servier Industries

The drug is intended for the symptomatic treatment of chronic stable angina pectoris in adults, as well as for the treatment of chronic heart failure (in patients with sinus rhythm and a heart rate of at least 70 beats per minute).

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Laboratoires Servier Industries

The drug is prescribed for the symptomatic treatment of chronic stable angina in adults, as well as to reduce the risk of cardiovascular events in patients with symptomatic chronic heart failure.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Bafna Pharmaceuticals Ltd.

The drug is indicated for the symptomatic treatment of chronic stable angina pectoris in adults with ischemic heart disease, as well as for the treatment of chronic heart failure in adults.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Bafna Pharmaceuticals Ltd

The drug is prescribed to adults for the symptomatic treatment of chronic stable angina (in ischemic heart disease and normal sinus rhythm) or for the treatment of chronic heart failure (NYHA class II-IV).

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Anorra Pharma Private Limited

The drug is prescribed to adults for the symptomatic treatment of chronic stable angina (with normal sinus rhythm and a heart rate of 70 bpm or higher), as well as for the treatment of chronic heart failure NYHA class II-IV.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Anorra Pharma Private Limited

The drug is prescribed for the symptomatic treatment of chronic stable angina in adults, as well as to reduce the risk of cardiovascular events in patients with chronic heart failure (provided there is a normal sinus rhythm and a heart rate of no less than 70 bpm).

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Ind-Swift Limited

The drug is prescribed for the symptomatic treatment of chronic stable angina in adults, as well as for the treatment of chronic heart failure in patients with normal sinus rhythm and a heart rate of no less than 70 beats per minute.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Ind-Swift Limited

The drug is prescribed for the symptomatic treatment of chronic stable angina in adults, as well as for the treatment of chronic heart failure (NYHA functional classes II-IV) in patients with systolic dysfunction.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Gedeon Richter Romania JSC

The drug is intended for the symptomatic treatment of chronic stable angina in adults with ischemic heart disease, as well as for the treatment of chronic heart failure (NYHA functional classes II-IV) under certain conditions.

Form: tablets, film-coated

ATC: C01EB17

Manufacturer: Gedeon Richter Romania JSC